Senior insider sale
President and CEO at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.72M
35.45K shares
What this filing means
AZAMIAN BOBAK R. plans to sell 35.45K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $2.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001628280-26-018285
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
35.45K
Shares to sell
$2.72M
Approx. market value
12.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
CASH
1/10/2017
12.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2017 | STOCK OPTION EXERCISE CASH | 12.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
12.50K
Market value
$1.02M
12/15/2025
—Completed
Units to sell
10.45K
Market value
$846.9K
12/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.50K
Market value
$859.8K
3/16/2026
Total
Units
35.45K
Value
$2.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 12.50K | $1.02M | — | Completed |
12/15/2025 | 10.45K | $846.9K | — | Completed |
| Planned — Approximate Date | ||||
3/16/2026 | 12.50K | $859.8K | NASDAQ | Planned |
| Total | 35.45K | $2.72M | ||